Leukocyte Antigen CD37

Preferred Label : Leukocyte Antigen CD37;

NCIt synonyms : Tetraspanin-26; CD37 Antigen; Tspan-26; Antigen CD37; CD37; Cell Differentiation Antigen 37; Leukocyte Surface Antigen CD37;

NCIt definition : Leukocyte antigen CD37 (281 aa, 32 kDa) is encoded by the human CD37 gene. This protein is involved in the regulation of humoral immunity.;

Détails

Origin ID

C102769;

UMLS CUI

C3537373;

OMIM relation
- Leukocyte surface antigen cd37 [OMIM gene]
See also inter- (CISMeF)
- CD37 [LOINC component]
- Leukocyte surface antigen cd37 [OMIM gene]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
concept_is_in_subset
- CTRP Biomarker Terminology [NCIt concept]
- CTRP Molecular Genetic Biomarker Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- Pediatric Oncology Target Cell Lineage Determinant Terminology [NCIt concept]
gene_encodes_gene_product
- CD37 Gene [NCIt concept]
- Immunoprotein Gene [NCIt concept]
gene_product_expressed_in_tissue
- B-Lymphocyte [NCIt concept]
gene_product_has_associated_anatomy
- Plasma Membrane [NCIt concept]
gene_product_has_biochemical_function
- Scaffolding Protein [NCIt concept]
gene_product_has_chemical_classification
- Transmembrane Protein [NCIt concept]
gene_product_has_structural_domain_or_motif
- Transmembrane Domain [NCIt concept]
gene_product_is_element_in_pathway
- Hematopoietic Cell Lineage Pathway [NCIt concept]
gene_product_plays_role_in_biological_process
- Humoral Immunity [NCIt concept]
- Immune System Process [NCIt concept]
- Protein-Protein Interaction [NCIt concept]
is_target
- Anti-CD20/CD37 Monoclonal Antibody Combination PSB202 [NCIt concept]
- Anti-CD37 MMAE Antibody-drug Conjugate AGS67E [NCIt concept]
- Anti-CD37 Monoclonal Antibody BI 836826 [NCIt concept]
- Anti-CD37-CAR-expressing T-lymphocytes [NCIt concept]
- Anti-CD37/DM1 Derivative Antibody-drug Conjugate Debio 1562M [NCIt concept]
- Ivicentamab [NCIt concept]
- Lilotomab [NCIt concept]
- Lutetium Lu 177 DOTA-Tetulomab [NCIt concept]
- Naratuximab Emtansine [NCIt concept]
- Otlertuzumab [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients